about
Melatonin in perioperative medicine: Current perspectiveSmartphone viewing distance and sleep: an experimental study utilizing motion capture technology.Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?Melatonin Modulates Neuronal Cell Death Induced by Endoplasmic Reticulum Stress under Insulin Resistance Condition.Melatonin Induced Changes in Specific Growth Rate, Gonadal Maturity, Lipid and Protein Production in Nile Tilapia Oreochromis niloticus (Linnaeus 1758)Circadian rhythms in gene expression: Relationship to physiology, disease, drug disposition and drug action.De novo sequencing of Hypericum perforatum transcriptome to identify potential genes involved in the biosynthesis of active metabolitesAntiinflammatory activity of melatonin in central nervous systemNight-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients.Structures and functions of insect arylalkylamine N-acetyltransferase (iaaNAT); a key enzyme for physiological and behavioral switch in arthropods.Beneficial effects of melatonin on stroke-induced muscle atrophy in focal cerebral ischemic rats.Reduction of Endogenous Melatonin Accelerates Cognitive Decline in Mice in a Simulated Occupational Formaldehyde Exposure Environment.Analysis of the mechanism by which melatonin inhibits human eosinophil peroxidase.Pathway Analysis Revealed Potential Diverse Health Impacts of Flavonoids that Bind Estrogen Receptors.Twenty-four hour non-invasive ambulatory blood pressure and heart rate monitoring in Parkinson's disease.Increasing doxorubicin activity against breast cancer cells using PPARĪ³-ligands and by exploiting circadian rhythmsProtective Effects of Silymarin, Alone or in Combination with Chlorogenic Acid and/or Melatonin, Against Carbon Tetrachloride-induced Hepatotoxicity.Melatonin in the management of perinatal hypoxic-ischemic encephalopathy: light at the end of the tunnel?Melatonin and human mitochondrial diseasesMotor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment.Melatonin regulation of biliary functions.Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.Clinical pharmacology of melatonin in the treatment of tinnitus: a review.Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy.Neuroendocrine Regulation of Anxiety: Beyond the Hypothalamic-Pituitary-Adrenal Axis.Potential Role of Microtubule Stabilizing Agents in Neurodevelopmental Disorders.Melatonin Supplementation May Improve the Outcome of Patients with Hemorrhagic Stroke in the Intensive Care Unit.Which is the best choice for gastroesophageal disorders: Melatonin or proton pump inhibitors?Melatonin promotes puromycin-induced apoptosis with activation of caspase-3 and 5'-adenosine monophosphate-activated kinase-alpha in human leukemia HL-60 cells.Melatonin treatment increases the transcription of cell proliferation-related genes prior to inducing cell death in C6 glioma cells in vitro.Melatonin levels in premenopausal women with fibromyalgia syndrome.Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model.Melatonin controlled apoptosis and protected the testes and sperm quality against bisphenol A-induced oxidative toxicity.Comparison of the Protective Effects of Melatonin and Silymarin Against Gentamicin-Induced Nephrotoxicity in Rats.Melatonin as a potential inhibitory agent in head and neck cancer.Melatonin Synergizes the Chemotherapeutic Effect of Cisplatin in Ovarian Cancer Cells Independently of MT1 Melatonin Receptors.The effects of a roundtrip trans-American jet travel on physiological stress, neuromuscular performance, and recovery.Effects of melatonin on physical fatigue and other symptoms in patients with advanced cancer receiving palliative care: A double-blind placebo-controlled crossover trial.Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.Systemic and transdermal melatonin administration prevents neuropathology in response to perinatal asphyxia in newborn lambs.
P2860
Q27015355-23102679-893F-479D-B1B5-AF7DA0E96F6CQ33453626-46DE9EAD-FD85-433A-BC97-BBD94F045E9DQ33723452-F6EB7235-85C7-4A59-A14A-C59974F5DDBAQ33852016-127BE02E-607F-4E8D-B4CB-64ABD0EC2C77Q33884102-067FE317-2AC4-42C3-A5C8-7C062CAF56AEQ34069298-A0D5EF34-7502-460E-B565-24032BE04A4DQ34364487-0BB19BBE-DAE9-4385-8E44-4BA691A0D1BCQ34402174-990F5861-BC1A-4437-A3B6-F1487F90BD0CQ35366244-BCD4F7C0-2808-42E4-864E-18478AA64D43Q35384063-98194174-9039-4D0C-AB0E-45E6A2E44F56Q35860290-E8F82C33-7FA2-4539-B8CF-09AD565E3EDAQ36732257-3BFAD31A-1304-4C67-BE3F-6A54A2534825Q36790186-A9D9DD89-4D4F-4645-99F4-7E2BA6B32937Q36841629-98FC7D7B-E022-4CAD-8D71-F4669032927EQ36845017-1287B3F3-D880-46CA-960F-B78752C8A4ECQ36965932-200330AA-EBE0-4284-A677-151166FD3876Q37149008-DEE61951-3E07-48FB-88E0-6DFD55883A44Q37302940-0AA35EE4-447A-4D20-8CFD-2C0B749909F0Q37715251-BDEA8EE4-53F4-4A05-B3A7-9D006B8F7556Q37868985-6CFD1EC6-3BE0-49C0-89CF-0550F0E0A057Q38201723-F4E7AC4E-269A-44C2-8472-B18053EADA82Q38306593-2CEE2C51-11B9-4948-A937-24B19A73A93CQ38322543-1C26608C-4B6D-4B7F-ADF9-68B5167250A9Q38467876-82C2BDFC-35D3-498C-B0C6-795906565735Q38869219-A2899EBA-8FAF-4CF4-819B-5F7ED1D2B31AQ41573058-3ACF552B-9A36-4790-81CB-8F6BF0452069Q42269856-41D0F9AE-F7C6-4F90-A69F-83652238ABC3Q42553733-190F59EC-D621-4355-A397-2460B505B155Q42756928-ADBFB0BA-ACC9-42C1-BD66-4982334199C5Q42959530-75A7C302-28EE-4F0F-B466-51E408218824Q43715875-5502291C-5212-45AF-9F0F-2FA099CD1707Q44099805-5E332E2E-4C76-4497-9A64-E614E2AF76F2Q46410924-4782FE7B-90A7-4E21-8254-CF9CF4B13D23Q46619010-A5BEA19B-6A90-4770-8100-A90E0EF900E2Q47112398-DEACD1D5-8DA1-4112-B720-2067070A2D28Q47169877-FFBEBA3C-3475-4C49-BF9E-A49D1862FAA7Q47848251-35B079DB-43EF-4211-AC47-1656AFBE1B5DQ48010176-945CEB9C-8BA6-4B88-80A4-D097F86A6DACQ49315568-9CC2E6DA-0EBD-42B9-A166-2BE6520C6043Q49719878-02BFCFC6-71AB-42CD-9579-1864D43A4B15
P2860
description
2007 nĆ® lÅ«n-bĆ»n
@nan
2007 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« ÕÕ„ÕæÖÕøÖÕ”ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2007 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« ÖÕ„ÕæÖÕ¾Õ”ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2007幓ć®č«ę
@ja
2007幓č«ę
@yue
2007幓č«ę
@zh-hant
2007幓č«ę
@zh-hk
2007幓č«ę
@zh-mo
2007幓č«ę
@zh-tw
2007幓č®ŗę
@wuu
name
Melatonin: therapeutic and clinical utilization.
@ast
Melatonin: therapeutic and clinical utilization.
@en
Melatonin: therapeutic and clinical utilization.
@nl
type
label
Melatonin: therapeutic and clinical utilization.
@ast
Melatonin: therapeutic and clinical utilization.
@en
Melatonin: therapeutic and clinical utilization.
@nl
prefLabel
Melatonin: therapeutic and clinical utilization.
@ast
Melatonin: therapeutic and clinical utilization.
@en
Melatonin: therapeutic and clinical utilization.
@nl
P1476
Melatonin: therapeutic and clinical utilization
@en
P2093
Ugur-Altun B
P304
P356
10.1111/J.1742-1241.2006.01191.X
P577
2007-02-13T00:00:00Z